JMIR Medical Informatics

Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures

Editor-in-Chief:

Christian Lovis, MD, MPH, FACMI, Division of Medical Information Sciences, University Hospitals of Geneva (HUG), University of Geneva (UNIGE), Switzerland


Impact Factor 2.96

JMIR Medical Informatics (JMI, ISSN 2291-9694; Impact Factor: 2.96) (Editor-in-chief: Christian Lovis MD MPH FACMI) is a PubMed/SCIE-indexed journal that focuses on clinical informatics, big data in health and health care, decision support for health professionals, electronic health records, ehealth infrastructures and implementation. In June 2021, the journal received an impact factor of 2.96. 

Published by JMIR Publications, JMIR Medical Informatics has a focus on applied, translational research, with a broad readership including clinicians, CIOs, engineers, industry and health informatics professionals.

JMIR Medical Informatics adheres to rigorous quality standards, involving a rapid and thorough peer-review process, professional copyediting, professional production of PDF, XHTML, and XML proofs (ready for deposit in PubMed Central/PubMed).

Recent Articles

Article Thumbnail
Theme Issue: Medical Informatics and COVID-19

Transitioning nonemergency, ambulatory medical care to virtual visits in light of the COVID-19 global pandemic has been a massive shift in philosophy and practice that naturally came with a steep learning curve for patients, physicians, and clinic administrators.

|
Article Thumbnail
Ontologies, Classifications, and Coding

Automatic e-coaching may motivate individuals to lead a healthy lifestyle with early health risk prediction, personalized recommendation generation, and goal evaluation. Multiple studies have reported on uninterrupted and automatic monitoring of behavioral aspects (such as sedentary time, amount, and type of physical activity); however, e-coaching and personalized feedback techniques are still in a nascent stage. Current intelligent coaching strategies are mostly based on the handcrafted string messages that rarely individualize to each user’s needs, context, and preferences. Therefore, more realistic, flexible, practical, sophisticated, and engaging strategies are needed to model personalized recommendations.

|
Article Thumbnail
Decision Support for Health Professionals

Cervical cancer has been recognized as a preventable type of cancer. As the assessment of all the risk factors of a disease is challenging for physicians, information technology and risk assessment models have been used to estimate the degree of risk.

|
Article Thumbnail
Viewpoints on and Experiences with Digital Technologies in Health

Real-world data (RWD) collected in routine health care processes and transformed to real-world evidence have become increasingly interesting within the research and medical communities to enhance medical research and support regulatory decision-making. Despite numerous European initiatives, there is still no cross-border consensus or guideline determining which qualities RWD must meet in order to be acceptable for decision-making within regulatory or routine clinical decision support. In the absence of guidelines defining the quality standards for RWD, an overview and first recommendations for quality criteria for RWD in pharmaceutical research and health care decision-making is needed in Austria. An Austrian multistakeholder expert group led by Gesellschaft für Pharmazeutische Medizin (Austrian Society for Pharmaceutical Medicine) met regularly; reviewed and discussed guidelines, frameworks, use cases, or viewpoints; and agreed unanimously on a set of quality criteria for RWD. This consensus statement was derived from the quality criteria for RWD to be used more effectively for medical research purposes beyond the registry-based studies discussed in the European Medicines Agency guideline for registry-based studies. This paper summarizes the recommendations for the quality criteria of RWD, which represents a minimum set of requirements. In order to future-proof registry-based studies, RWD should follow high-quality standards and be subjected to the quality assurance measures needed to underpin data quality. Furthermore, specific RWD quality aspects for individual use cases (eg, medical or pharmacoeconomic research), market authorization processes, or postmarket authorization phases have yet to be elaborated.

|
Article Thumbnail
Machine Learning

Traditional monitoring for adverse events following immunization (AEFI) relies on various established reporting systems, where there is inevitable lag between an AEFI occurring and its potential reporting and subsequent processing of reports. AEFI safety signal detection strives to detect AEFI as early as possible, ideally close to real time. Monitoring social media data holds promise as a resource for this.

|
Article Thumbnail
Machine Learning

Hypoglycemia is a common adverse event in the treatment of diabetes. To efficiently cope with hypoglycemia, effective hypoglycemia prediction models need to be developed.

|
Article Thumbnail
Machine Learning

Hypoglycemia is a common adverse event in the treatment of diabetes. To efficiently cope with hypoglycemia, effective hypoglycemia prediction models need to be developed.

|
Article Thumbnail
Machine Learning

Sepsis is diagnosed in millions of people every year, resulting in a high mortality rate. Although patients with sepsis present multimorbid conditions, including cancer, sepsis predictions have mainly focused on patients with severe injuries.

|
Article Thumbnail
Machine Learning

Acute respiratory distress syndrome (ARDS) is a condition that is often considered to have broad and subjective diagnostic criteria and is associated with significant mortality and morbidity. Early and accurate prediction of ARDS and related conditions such as hypoxemia and sepsis could allow timely administration of therapies, leading to improved patient outcomes.

|
Article Thumbnail
Adoption and Change Management of eHealth Systems

New artificial intelligence (AI) tools are being developed at a high speed. However, strategies and practical experiences surrounding the adoption and implementation of AI in health care are lacking. This is likely because of the high implementation complexity of AI, legacy IT infrastructure, and unclear business cases, thus complicating AI adoption. Research has recently started to identify the factors influencing AI readiness of organizations.

|
Article Thumbnail
Machine Learning

Kidney transplantation is the preferred treatment option for patients with end-stage renal disease. To maximize patient and graft survival, the allocation of donor organs to potential recipients requires careful consideration.

|

We are working in partnership with